Latest News


Research to inform new guidelines on the safe use of medicines .

Two Royal North Shore Hospital clinician researchers will play a key role in a national research project to improve the use of medications across the community. Head of the Department of Clinical Pharmacology and Kolling researcher Professor Sarah Hilmer and Head of the Department of General Practice Associate Professor Fiona Robinson will help drive the project which has been awarded more than $2......
Read more

Category: Funding support, Research Excellence

Recognition for a remarkable career.

Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll. Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice and governa.....
Read more

Category: Awards, Cardiovascular and Renal Research, Research Excellence

Researchers join celebrations for national award.

Kolling Institute researchers have been recognised with a prestigious award for an initiative to support people to return to work after injury. The project, named Early Matched Care at Australia Post, was named the 2021 Winner of Comcare’s national Recovery at and Return to Work Award. The research team was led by Professor Michael Nicholas, from the Pain Management Research Centre at RNSH and the .....
Read more

Category: Awards, Research Excellence

International knee transplant study to inform future care.

New funding announced by the Federal Government will see researchers from the Kolling Institute and the University of Sydney drive an international study to determine the best treatment for those with knee cartilage damage. More than $1 million dollars has been awarded through a collaborative research grant scheme involving Australia’s National Health and Medical Research Council and the National I.....
Read more

Category: Funding support, Musculoskeletal Research

Kolling researchers join global effort to reduce heart disease in women.

Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioners of The La.....
Read more

Category: Cardiovascular and Renal Research

Researchers to identify safer and more effective treatment pathways for rheumatoid and psoriatic arthritis.

Kolling researcher Professor Lyn March will lead a large, collaborative national trial to improve treatments and outcomes for those with disabling rheumatoid and psoriatic arthritis. Federal Government MRFF funding will see more than $2.7 million invested in the project which will involve 400 participants across the country. Professor March, who is also the head of the Department of Rheumatology at.....
Read more

Category: Funding support, Musculoskeletal Research

Age and sex influence the adverse effects of multiple medications.

There are calls for a carefully-considered, tailored approach to the prescription of multiple medicines with new research finding a person’s age and sex influence the impact of multiple medications. More than half of older Australians take five or more regular medications, with the higher number of medications directly linked to a higher chance of adverse reactions, like falls, confusion and frailt.....
Read more

Category: Neuroscience and Pain Research, New Treatment

Technology to bring relief to those with low back pain.

With many of us looking to adopt a healthier lifestyle, researchers say a new approach may not only deliver benefits for your heart and waistline but may reduce low back pain as well. The condition affects one in six Australians or four million people and is the leading cause of adult musculoskeletal pain worldwide. Researchers from the University of Sydney and the Kolling Institute have launched a.....
Read more

Category: Musculoskeletal Research, Research Excellence

High tech project offers hope for Parkinson’s treatment.

Kolling researchers are set to lead a ground-breaking project to identify new drug therapies for those with Parkinson's disease. The project has been made possible following Federal Government funding through the National Drug Discovery Centre. Senior Kolling researcher Dr Daniel Whiten has welcomed the announcement, saying the funding will help our team translate our scientific progress into an ef.....
Read more

Category: Funding support

First large-scale trial of stem cell therapy for knee osteoarthritis launched.

Kolling researcher Professor David Hunter will lead one of the world’s largest clinical trials into the effectiveness of stem cell therapy for those with knee osteoarthritis. More than 400 participants will be recruited for the SCUlpTOR study which will see trial sites established at Royal North Shore Hospital and the Menzies Institute in Hobart. Professor Hunter, the Florance and Cope Chair of Rh.....
Read more

Category: Musculoskeletal Research, New Treatment